Table 1.
Univariate and multivariate analyses of factors for predicting overall survival in AA prostate cancer patients.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Variables | HR | 95% CI | P value | HR | 95% CI | P value |
miRNA expression (High vs Low) | 7.6 | 1.7–35.3 | 0.0076 | 22.4 | 2.3–222.4 | 0.0078 |
Age (≥62 vs <62 years) | 2.5 | 0.8–7.5 | 0.1 | 0.2 | 0.03–1.6 | 0.1 |
T classification (T3/T4 versus T2) | 1.6 | 0.3–4.2 | 0.81 | 8.9 | 0.9–85.6 | 0.057 |
PSA (<10 vs ≥10) | 1.6 | 0.5–4.9 | 0.37 | 0.02 | 0.0006–1.0 | 0.048 |
PSA failure (Positive vs Negative) | 1.4 | 0.4–4.1 | 0.59 | 0.7 | 0.10–4.7 | 0.68 |
Gleason Score (8–10 vs 5–7) | 2.2 | 0.8–6.3 | 0.1 | 0.44 | 0.04–4.6 | 0.49 |
Univariate and multivariate analyses of factors for predicting overall survival in EA prostate cancer patients. | ||||||
Univariate analysis | Multivariate analysis | |||||
Variables | HR | 95% CI | P value | HR | 95% CI | P value |
miRNA expression (High vs Low) | 1.9 | 0.6–5.5 | 0.25 | 1.1 | 0.1–8.3 | 0.91 |
Age (≥62 vs <62 years) | 0.8 | 0.3–2.5 | 0.59 | 0.5 | 0.1–2.2 | 0.34 |
T classification (T3/T4 versus T2) | 4.2 | 1.1–16.0 | 0.036 | 2.0 | 0.2–17.0 | 0.53 |
PSA (<10 vs ≥10) | 2.1 | 0.7–6.0 | 0.17 | 1.7 | 0.2–13.3 | 0.45 |
PSA failure (Positive vs Negative) | 4.7 | 1.3–17.7 | 0.02 | 2.3 | 0.2–19.1 | 0.45 |
Gleason Score (8–10 vs 5–7) | 2.1 | 0.6–8.0 | 0.25 | 0.8 | 0.1–4.0 | 0.74 |